This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

THEODORE H. SPAET, M.D.; MONA KROPATKIN, B.S.

AMA Arch Intern Med. 1958;102(4):558-561.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Certain of the blood-clotting factors have a number of properties in common. These properties include affinity for the insoluble salts of heavy metals (i. e., barium sulfate), relative heat lability and storage stability, and lack of utilization during the course of clotting. The last-named property, whereby serum contains these factors in undiminished titer, has led some investigators to use the term "serum factors." The presently accepted "serum factors" are Factor VII, plasma thromboplastin component (PTC), and Stuart factor.¹

Except for its utilization during clotting, prothrombin shares the above-mentioned properties of the "serum factors." These similarities have suggested the "serum factors" are derivatives of or share a common synthetic pathway with prothrombin. Evidence for this view has been provided by the finding that all are depressed following administration of bishydroxycoumarin (Dicumarol) and related drugs,^2-5 suggesting that vitamin K is necessary for their synthesis. Moreover, it has been possible to . . . [Full Text PDF of this Article]

Author Affiliations
New York

From the Department of Hematology, Division of Laboratories, Montefiore Hospital.

Footnotes
Submitted for publication Jan. 23, 1958.

This study was supported by Grant No. H-2442 of the National Heart Institute, N. I. H., U. S. P. H. S.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?